Title : Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma.

Pub. Date : 2008 Nov

PMID : 18771527






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma. Irinotecan carboxylesterase 2 Homo sapiens
2 Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma. Irinotecan carboxylesterase 2 Homo sapiens
3 Interestingly, high expression of hCE-2 represented the nature of normal plasma cells, suggesting that hCE-2 could efficiently generate SN-38 within the plasma cells. Irinotecan carboxylesterase 2 Homo sapiens
4 Interestingly, high expression of hCE-2 represented the nature of normal plasma cells, suggesting that hCE-2 could efficiently generate SN-38 within the plasma cells. Irinotecan carboxylesterase 2 Homo sapiens
5 As expected, higher sensitivity to CPT-11 was observed in hCE-2-overexpressing U266 cells than mock U266 cells. Irinotecan carboxylesterase 2 Homo sapiens